EquityZen Growth Technology Fund LLC - Series 235
Raised
$2M
Investors
56
Min Invest
$4,986
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 235 is a Delaware-domiciled single-series SPV that raised $2.0M from 56 investors under Rule 506(b) and Section 3(c)(1) exemptions, with a $5K minimum investment. Filed August 30, 2018 by EquityZen Advisors LLC, this vehicle is part of the EquityZen pre-IPO platform, which operates nearly 1,900 related EDGAR entities providing accredited investors access to private company equity.
This pre-IPO offering follows the standard EquityZen model of low minimum investments ($5K) enabling retail accredited access to private growth companies. The 506(b) exemption with 3(c)(1) fund treatment is typical for EquityZen's single-company series vehicles, allowing up to 99 beneficial owners without general solicitation.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Shriram Bhashyam
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
